COMMUNIQUÉS West-GlobeNewswire

aTyr Pharma to Present at the Cantor Fitzgerald 2018 Global Healthcare Conference
20/09/2018
SAN DIEGO, Sept. 20, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today [...]
Project HOPE Team Responds to Urgent Health Needs as Venezuelans Flee
20/09/2018
Millwood, VA, Sept. 20, 2018 (GLOBE NEWSWIRE) -- Project HOPE announced today that it is deploying an emergency response team to address an exodus of people fleeing political turmoil and an economic collapse in [...]
Thrive Health and Wellness Festival Canmore
20/09/2018
Ticket sales begin for the inaugural Bow Valley festival CANMORE, Alberta, Sept. 20, 2018 (GLOBE NEWSWIRE) -- Today, Thrive, the first Health and Wellness festival in the Bow Valley, announced that they have released [...]
Rubius Therapeutics to Participate in the Leerink Partners Roundtable Series: Rare Disease & Immuno-Oncology
20/09/2018
CAMBRIDGE, Mass., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a biotechnology company pioneering the development of a new class of ready-to-use cellular therapies, announced today that [...]
Marinus Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
20/09/2018
RADNOR, Pa., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (the “Company”, “Marinus”), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat [...]
Opiant Pharmaceuticals Announces Contract with Biomedical Advanced Research and Development Authority for Up to $4.6 Million to Accelerate Development of OPNT003, Nasal Nalmefene, for Treatment of Opioid Overdose
20/09/2018
SANTA MONICA, Calif., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions and drug overdose, today [...]
XBiotech annonce l’arrivée du Dr Alice Gottlieb au sein de son équipe, une dermatologue et chercheuse de renom
20/09/2018
AUSTIN, Texas, 20 sept. 2018 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ : XBIT) annonce aujourd’hui l’arrivée du Dr Alice Gottlieb (M.D., Ph.D.) au sein de son comité scientifique consultatif (Scientific Advisory Board, [...]
Reeves County Hospital District Selects Cerner for Improved Rural Patient Care
20/09/2018
PECOS, Texas, Sept. 20, 2018 (GLOBE NEWSWIRE) -- Reeves County Hospital District has selected Cerner, a global leader in health care technology, to implement a new integrated electronic health record (EHR) and revenue [...]
Evolus to Present at the Cantor Global Healthcare Conference
20/09/2018
IRVINE, Calif., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ:EOLS), a company dedicated to aesthetic medicine, announced today that members of management will present at the Cantor Global Healthcare [...]
PCI Biotech: Mandatory notification regarding exercise and trade of subscription rights
20/09/2018
Oslo, September 20, 2018 - Overview of mandatory notification regarding exercise and trade of subscription rights. Management and the board of directors of PCI Biotech Holding ASA ("PCI Biotech" or "the Company") are [...]
Tetraphase Pharmaceuticals Announces Adoption of Commission Decision Granting Marketing Authorisation Approval in the European Union for XERAVA™ (eravacycline) for the Treatment of Complicated Intra-Abdominal Infections
20/09/2018
– Broad Product Label for Treatment of Complicated Intra-Abdominal Infections – – Phased Commercial Launch Expected in the First Half of 2019 – WATERTOWN, Mass., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Tetraphase [...]
NeuroMetrix Reports Discussion of Quell Wearable Pain Relief Technology on the Fox Business Network
20/09/2018
WALTHAM, Mass., Sept. 20, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), reported that its President and CEO, Dr. Shai N. Gozani, yesterday participated in a discussion of the opioid crisis and the Company’s [...]
Study finds learning communities across country support adoption of health care innovations
20/09/2018
Appears in October 2018 issue of The Joint Commission Journal on Quality and Patient Safety OAKBROOK TERRACE, Ill., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Learning communities can provide a rich, collaborative environment [...]
Alberta Medical Association inducts new president and welcomes Canadian Medical Association president
20/09/2018
CALGARY, Alberta, Sept. 20, 2018 (GLOBE NEWSWIRE) -- The Alberta Medical Association will install its president for 2018-19 on Saturday, September 22, during its Annual General Meeting and Representative Forum at the [...]
Alberta Medical Association honours Albertans for their extraordinary contributions to health care
20/09/2018
CALGARY, Alberta, Sept. 20, 2018 (GLOBE NEWSWIRE) -- On Friday, September 21, the Alberta Medical Association will honour Albertans who have dedicated their lives and their careers to improving the health care and [...]
UPDATE— Taconic Biosciences Becomes the First Animal Model Provider on General Services Administration Contract Schedule
20/09/2018
RENSSELAER, N.Y., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing genetically engineered rodent model solutions, announces a new relationship with Government Scientific Source (GSS [...]
VALNEVA Announces Extension of Drawdown Period for its Existing European Investment Bank Loan
20/09/2018
Valneva Announces Extension of Drawdown Period for its Existing European Investment Bank Loan Saint Herblain (France), September 20, 2018 - Valneva SE ("Valneva" or "the Company"), a commercial stage biotech company [...]
VALNEVA obtient une prolongation du prêt de la Banque Européenne d'Investissement
20/09/2018
Valneva obtient une prolongation du prêt de la Banque Européenne d'Investissement Saint-Herblain (France), 20 septembre 2018 - Valneva SE ("Valneva" ou "le Groupe"), société de biotechnologie dédiée au développement, à [...]
Issue of Shares & PDMR Announcement
20/09/2018
LONDON, Sept. 20, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]

Pages